PMI product sees movement.
WASHINGTON — The United States Food and Drug Administration (FDA) said that Philip Morris Products S.A.’s modified risk tobacco product (MRTP) application for the latest iteration of the IQOS heat-not-burn system holder and charger. The Center for Tobacco Products at the FDA recently opened up the Federal Register for public comments on the MRTP application.
“PMI is fully committed to a smoke-free future, one where we completely replace cigarettes with scientifically substantiated smoke-free alternatives that are a better choice for adults who would otherwise continue smoking,” said Jacek Olczak, the chief executive officer of Philip Morris International. “Our commitment to a science-based future is unmatched, having invested more than $8 billion since 2008 on smoke-free products.”
Olczak added: “This application underscores PMI’s on-going commitment to make new innovations available to American adult smokers through the FDA process; the confidence we have in our science; and our belief that public scrutiny and open engagement with governments is vital to achieving a smoke-free future.”
PMI and its North American products subsidiary submitted the application with the intention of scoring an MRTP status similar to the one granted to the IQOS 2.4 system on July 7, 2020.
The IQOS 2.4 system is the only electronic nicotine delivery system to be granted marketing authorization as a modified tobacco product with a less harmful characteristic than smoking.
“To authorize MRTP consumer communications, the FDA’s Center for Tobacco Products is required by law to conclude that a product is appropriate to promote the public health,” states a press statement from PMI.
IQOS is sold in the United States by PMI, through a special agreement with Altria Group.
The device is popular all over the world, especially with product variations in Japan. Heated tobacco products are also considered less harmful forms of nicotine delivery than traditional cigarettes or other combustible tobacco products.